文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > 基因多态性Statin myotoxicity A review of genetic susceptibility factors
侵权投诉

基因多态性Statin myotoxicity A review of genetic susceptibility factors

8M.Needham,F.L.Mastaglia/NeuromuscularDisorders24(2014)4–15

passbytheliver.Atorvastatin,simvastatinandlovastatinaremetabolizedbythecytochromep450(CYP3A4)enzyme,while uvastatinusescytochromep450(CYP2C9).Simvastatinalsohasa nitytoCYP2D6aswellasCYP2C9[104].RosuvastatinandpravastatinarenotmetabolizedbytheCYPenzymesandareeliminatedlargelyasunchangeddrugs[34].ItiswellknownthatconcurrentuseofCYP3A4inhibitorscanraisetheconcentrationofthedrugintheserum,andincreasetheriskoftoxicityincludingrhabdomyolysis.Approximatelyhalfofallprescriptiondrugsaremetabolizedbythispathway[105].Manycasesofstatin-inducedrhabdomyolysisoccurredinassociationwithdrugsinteractingwiththissystem,particularlygem brozil[17].Geneticpolymorphismscancauseincreasedenzymeactivityresultinginanelevateddruglevelandthereforepotentialtoxicity,oradecreasedorabsentenzymeactivityresultinginalackoftherapeutice cacy[106].WhilstCYP3A4isthemostimportant,itdoesnothavemanypolymorphisms[105],andthusfardoesnotseemtobeassociatedwithstatin-inducedmusclee ects[107,108].CYP2D6ontheotherhandhashadmorethan50variantsdescribed,allowingsubgroupsofpoormetabolizers,extensivemetabolisersandultrarapidmetaboliserstobede ned[109].Mulderandcolleagues[110]analysedtheCYP2D6genotypesin88simvastatin-treatedpatients,andfoundthehighestincidenceofintolerabilityinthehomozygouspatientsforthe‘defective’CPY2D6allelesleadingtodecreasedenzymeactivity,butastatisticallysigni cantlargerdecreaseinserumcholesterol.Zuccaroontheotherhandfoundpoormetabolisersdidnothaveanincreasedrate

Table2

Geneticpolymorphismsreportedtobeassociatedwithstatin-myopathy.

Study

Statin

Outcomesmeasured

Genesinvestigated*

Singlenucleotidepolymorphism(SNP)oralleleassociatedwiththemeasuredoutcome

c.521CCgenotypeofSLCO1B1a ectspharmacokineticsofpravastatinSLCO1B1*5allele(mostsigni cantforsimvastatin)

c.521CCgenotypea ects

pharmacokineticsofsimvastatinacidrs4149056SNP(intheCallele)

Statin

transporterproteins

Niemietal.[93,96]Pravastatin(n=32)FluvastatinVoora[94](n=509)Simvastatin

AtorvastatinPravastatin

Pasanen[95]Simvastatin(n=32)

SEARCH[97]Simvastatin(n=175initial)

Pharmacokinetics,(plasmaconcentration)

Drugdiscontinuation,myalgia,HyperCKaemia,Pharmacokineticsofsimvastatinacid

Myopathyandcholesterolloweringe ects

SLCO1B1

CYP2D6,CYP2C8,CYP2C9,CYP3A4/SLCO1B1SLCO1B1

Genomewidestudywith>300,000markers,(IlluminaHumanHap300-Duopanel),CYP3A4/SLCO1B1SLCO1B1gene

Donnelly[98](n=4196)

Multiple(majoritysimvastatin)

Fiegenbaumetal.[102](n=116)

Simvastatin

Statinintolerance

(biochemical,discontinuationofdrug,switchingorreducingdoseofdrug),andcholesterolloweringe ect

ReductioninserumCYP3A4,CYP3A5,cholesterolandLDLsABCB1

rs4149056(Val174Ala)associatedwith

higherintolerance,rs2306283

(Asp130Asn)associatedwithlowerintolerance

1236Talleleand2677G>A/T

polymorphisminABCB1genehadmoresigni cantreductionsinserumcholesterolandLDL

Reducedfrequencyof1236T,2677non-Gand3435Thaplotypesinpatientswithmyalgia

CYP2D6*4(G1934mutation),CYP2D6*3(A2637deletion)andCYP2D6*5(CYP2D6genedeletion)(associatedwith‘poormetaboliser’phenotype).Homozygosityassociatedwithhighestincidenceintolerabilityandstrongerdecreaseinserumcholesterol*

4alleleassociatedwithmuscleevents

Presenceofmyalgia’s

Statin

metabolismgenes

Mulderetal.[110](n=88)

Simvastatin

DiscontinuationoftherapyCYP2D6duetoadverseevents

(gastrointestinal>myalgia’s),ande cacyofcholesterollowering(serumcholesterollevels)

Frudakisetal.[108]Atorvastatin,Frequencyofmuscleevents(n=263samples)Simvastatin(myalgia,CKelevation,

rhabdomyolysis)

Wilkeetal.[107]AtorvastatinElevatedCKandpresence(n=137)myalgia

CYP2D6(388SNP’s

investigated)CYP3A

CYP3A5*3allele(noincreasein

incidenceofmyopathy,buthigherCKrisesinhomozygotesexperiencingmyalgia)

上一页第5页

TOP相关主题

你可能喜欢

热门文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email